PIGM

phosphatidylinositol glycan anchor biosynthesis class M, the group of Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis

Basic information

Region (hg38): 1:160024953-160031990

Links

ENSG00000143315NCBI:93183OMIM:610273HGNC:18858Uniprot:Q9H3S5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency (Limited), mode of inheritance: AR
  • hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency (Moderate), mode of inheritance: AR
  • hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency (Supportive), mode of inheritance: AR
  • hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency (Limited), mode of inheritance: Unknown

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Glycosylphosphatidylinositol biosynthesis defect 1ARBiochemical; Hematologic; Neurologic; PharmacogenomicMedical treatment may be beneficial (eg, prophylactic oral anticoagulants to prevent thrombosis; sodium phenylbutyrate for seizure control); Awareness of coagulopathies may be beneficial in terms of medical management, especially in situations such as surgery; Hepatic-metabolized agents should be avoidedBiochemical; Hematologic; Neurologic16767100; 17442906; 19168132; 31445883

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PIGM gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIGM gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
16
clinvar
2
clinvar
18
missense
64
clinvar
3
clinvar
67
nonsense
1
clinvar
1
start loss
1
clinvar
1
frameshift
1
clinvar
1
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 2 66 16 6

Variants in PIGM

This is a list of pathogenic ClinVar variants found in the PIGM region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-160030471-G-C Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Uncertain significance (Jun 25, 2023)3015199
1-160030482-TTCTC-T Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency • not specified • PIGM-related disorder Uncertain significance (Feb 22, 2024)503728
1-160030523-T-G Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Uncertain significance (Nov 15, 2022)1716499
1-160030541-T-C Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Uncertain significance (Jul 12, 2022)1424323
1-160030547-A-G Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Uncertain significance (Jun 23, 2023)2151297
1-160030548-G-C not specified Uncertain significance (Mar 06, 2023)2472179
1-160030590-T-C Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency • PIGM-related disorder Benign (Jan 24, 2024)1166403
1-160030597-T-C Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Likely benign (Oct 14, 2023)2906336
1-160030640-C-A Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Uncertain significance (Feb 28, 2022)1973487
1-160030645-A-T Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Benign (Jan 30, 2024)1164402
1-160030647-A-C Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Uncertain significance (Sep 01, 2022)1916848
1-160030650-A-G Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Uncertain significance (Feb 22, 2024)2071768
1-160030698-G-A Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Benign (Apr 01, 2023)2056194
1-160030698-G-C Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency • not specified Uncertain significance (Oct 27, 2023)1020292
1-160030723-G-A Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Likely benign (Jul 07, 2020)1121017
1-160030739-T-G Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Uncertain significance (Jun 30, 2022)1055901
1-160030741-G-A Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency • PIGM-related disorder Benign/Likely benign (Aug 30, 2023)1170560
1-160030758-T-A not specified Uncertain significance (Aug 13, 2021)2244698
1-160030778-G-T PIGM-related disorder Uncertain significance (Aug 18, 2022)2636415
1-160030779-T-C not specified Uncertain significance (Dec 19, 2023)426742
1-160030781-T-C PIGM-related disorder Uncertain significance (Dec 02, 2023)2628534
1-160030790-C-T Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency • not specified Uncertain significance (May 10, 2024)640196
1-160030802-AGGTCTCTGT-A See cases Uncertain significance (May 10, 2021)1690632
1-160030873-G-C Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency Likely benign (Aug 16, 2022)1124438
1-160030877-A-G not specified Uncertain significance (Jun 19, 2024)2358869

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PIGMprotein_codingprotein_codingENST00000368090 14322
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00005390.69900000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.08112152121.020.00001032735
Missense in Polyphen7279.7810.902471063
Synonymous0.09229091.10.9880.00000463893
Loss of Function0.957811.50.6955.05e-7146

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Mannosyltransferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers the first alpha-1,4-mannose to GlcN-acyl-PI during GPI precursor assembly. {ECO:0000269|PubMed:11226175}.;
Disease
DISEASE: Glycosylphosphatidylinositol deficiency (GPID) [MIM:610293]: Autosomal recessive trait that results in a propensity to venous thrombosis and seizures. Deficiency is due to a point mutation in the regulatory sequences of PIGM that disrupts binding of the transcription factor SP1 to its cognate promoter motif, leading to a strong reduction of expression. {ECO:0000269|PubMed:16767100}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human);Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins (Consensus)

Recessive Scores

pRec
0.102

Intolerance Scores

loftool
0.675
rvis_EVS
-0.27
rvis_percentile_EVS
34.6

Haploinsufficiency Scores

pHI
0.0995
hipred
N
hipred_score
0.239
ghis
0.557

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.371

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pigm
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
GPI anchor biosynthetic process
Cellular component
endoplasmic reticulum membrane;integral component of membrane
Molecular function
transferase activity, transferring hexosyl groups